Published in Vaccine Weekly, October 26th, 2011
"The recent decision by our partner to proceed to the next stage is very encouraging and validates the importance and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.